An Ulcerated Nodule on the Toe in an Elderly Patient: A Quiz

Chiattone C, Civallero M, Fischer T, Miranda E, Manni M, Zing NPC, et al. Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: report from the prospective international T-cell lymphoma project. Hematol Oncol 2022; 40: 953–961.

https://doi.org/10.1002/hon.3074 DOI: https://doi.org/10.1002/hon.3074

Nguyen KA, Su C, Bai HX, Zhang Z, Xiao R, Karakousis G, et al. Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database. Br J Haematol 2018; 181: 196–204.

https://doi.org/10.1111/bjh.15145 DOI: https://doi.org/10.1111/bjh.15145

Amador C, Feldman AL. How I diagnose anaplastic large cell lymphoma. Am J Clin Pathol 2021; 155: 479–497.

https://doi.org/10.1093/ajcp/aqab012 DOI: https://doi.org/10.1093/ajcp/aqab012

Polski JM, Janney CG. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma. Mod Pathol 1999; 12: 903–906.

Rigaud C, Knörr F, Brugières L, Woessmann W. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents. Best Pract Res Clin Haematol 2023; 36: 101444.

https://doi.org/10.1016/j.beha.2023.101444 DOI: https://doi.org/10.1016/j.beha.2023.101444

Horwitz S, O’Connor OA, Pro B, Trümper L, Iyer S, Advani R, et al, The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Ann Oncol 2022; 33: 288–298.

https://doi.org/10.1016/j.annonc.2021.12.002 DOI: https://doi.org/10.1016/j.annonc.2021.12.002